ScholarIQanswers from OpenAlex
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
PaperCitations, authors & open-access status
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 911 citations, 2018 year and green oa status.
911
Citations
2018
Year
green
OA Status